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This is a weekly summary of the daily COVID-19 health evidence summary (HES) which are based 
on 3 hours of desk-based research each day. The summary is not intended to be a comprehensive 
summary of available evidence on COVID-19 but aims to make original documents easily 
accessible to decision makers which, if relevant to them, they should go to before making 
decisions. 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
01.06.2020 COVID-19 mortality 
is associated with 
pre-existing 
disease burden: a 
cross-country 
analysis 
Bulletin WHO 
| Article  
 Cross-sectional 
study of 45 HICs 
and 42 non-HICs 
using global burden 
of disease data  
 Whilst in HICs C19 
mortality was 
associated with pre-
existing disease 
burden, no 
association was 
found between 
disease burdens and 
C19 mortality rate 
for non-HICs 
Mortality, 
co-morbidity 
02.06.2020 Clinical features of 
COVID-19 patients 
in Abdul Wahab 
Sjahranie Hospital, 
Samarinda, 
Indonesia 
medRxiv | 
Preprint (not 
peer 
reviewed) 
 The majority of 
COVID-19 patients 
are male. COVID-19 
comorbidities were 
found in several 
patients. The main 
clinical symptoms of 
COVID-19 in this 
study were cough, 
sore throat, and 
fever.  
 The abnormal 
laboratory finding in 
 Morbidity 
2 
COVID-19 patients 
is anemia, an 
increase in AST and 
ALT levels, and 
chest x-ray images 
of pneumonia. All 
patients are in mild 
condition. The 
average length of 
hospital admission 
patients to discharge 
is more than 30 
days.  
 The inability of a 
local laboratory to 
check for positive 
confirmation of 
COVID-19 makes 
the admission period 
of the patient in the 
hospital very long. 
The availability of 
RT-PCR tests at 
Abdul Wahab 
Sjahranie Hospital 
Samarinda will 
greatly assist the 
further management 
of COVID-19 
patients.. 
29.05.2020 Neuropathogenesis 
and neurologic 
manifestations of 
the coronaviruses 
in the age of 
coronavirus 
disease 2019: A 
Review 
JAMA 
Neurology | 
Review 
 MERS-CoV and 
SARS-CoV-1 are 
known to cause 
disease in the 
central and 
peripheral nervous 
systems 
 The pulmonary 
manifestations of 
C19 have been well 
described in the 
literature but 
emerging evidence 
suggests C19 has 
neurologic 
consequences as 
well 
 This review 
summarises 
available information 
regarding 
neurological 
disorders associated 
with C19  which may 
lead to improved 
 Morbidity | 
Neurological 
3 
clinical outcomes 
and better treatment 
algorithms. This 
review also 
highlights where 
further studies are 
required  
29.05.2020 Mortality and 
pulmonary 
complications in 
patients undergoing 
surgery with 
perioperative 
SARS-CoV-2 
infection: an 
international cohort 
study 
The Lancet | 
Article 
 Analysis of 1128 
patients who had 
surgery between 1 
Jan and 31 Mar 
2020 
 Postoperative 
pulmonary 
complications occur 
in half of patients 
with perioperative 
SARS-CoV-2 
infection and are 
associated with high 
mortality 
 Thresholds for 
surgery during the 
C19 pandemic 
should be raised 
compared to normal 
practice, especially 
in men aged 70 
years and older 
 Postponing non-
urgent procedures 
and promoting non-
operative treatment 
to delay or avoid the 
need for surgery 
should be 
considered  
 Mortality | 
surgery 
29.05.2020 Clinical 
characteristics and 
risk factors 
associated with 
COVID-19 disease 
severity in patients 
with cancer in 
Wuhan, China: a 
multicentre, 
retrospective, 
cohort study 
The Lancet 
Oncology | 
Article 
 Patients with cancer 
and COVID-19 were 
more likely to 
deteriorate into 
severe illness than 
those without cancer 
 Risk factors 
identified in this 
study may help early 
clinical surveillance 
of disease 
progression of C19 
in patients with 
cancer 
Morbidity | 
NCD 
4 
29.05.2020 Clinical 
characteristics, 
outcomes, and risk 
factors for mortality 
in patients with 
cancer and COVID-
19 in Hubei, China: 
a multicentre, 
retrospective, 
cohort study 
The Lancet 
Oncology | 
Article 
 Patients with cancer 
and COVID-19 
admitted to hospital 
had a high case-
fatality rate  
 Unfavourable 
prognostic factors, 
including receiving 
chemotherapy within 
4 weeks before 
symptom onset and 
male sex, may help 
clinicians identify 
patients at high risk 
of dying 
Mortality | 
NCD 
Epidemiology and modelling 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
03.06.2020 Prevalence of 
asymptomatic 
SARS-CoV-2 
infection: a 
narrative 
review 
Annals of 
Internal 
Medicine | 
Review 
 It is likely that 40 
to 45% of those 
infected with 
SARS-CoV-2 will 
remain 
asymptomatic – 
the virus may 
silently spread 
more than 
previously 
estimated 
 Asymptomatic 
persons can 
transmit SARS-
CoV-2 and 
perhaps longer 
than 14 days 
 Absence of 
symptoms in 
infected persons 
might not imply 
absence of harm. 
More research is 
needed to 
determine the 
significance of 
subclinical lung 
changes 
 Testing 
programmes must 
broaden to include 
Asymptomatic, 
transmission, 
testing 
5 
those without 
symptoms 
 Limitation – most 
data under review 
was from cohort 
studies 
 It remains difficult 
to distinguish 
between 
asymptomatic and 
presymptomatic 
persons 
02.06.2020 Effects of non-
pharmaceutical 
interventions 
on COVID-19 
cases, deaths, 
and demand 
for hospital 
services in the 
UK: a 
modelling 
study 
(Included for 
possible 
lessons learnt 
and projections 
relevant for 
LMIC) 
Lancet | 
Article 
 This study 
assesses the 
potential impact of 
different control 
measures for 
mitigating the 
burden of COVID-
19 in the UK. 
 The four base 
interventions 
modelled were 
school closures, 
physical 
distancing, 
shielding of people 
aged 70 years or 
older, and self-
isolation of 
symptomatic 
cases. 
 Conclusion that 
intensive 
interventions with 
lockdown periods 
would need to be 
in place for a large 
proportion of the 
coming year to 
prevent health-
care demand 
exceeding 
availability. 
Modelling 
29.05.2020 Statistical 
analysis of the 
impact of 
environmental 
temperature on 
the exponential 
growth rate of 
PLOS One/ 
Research 
article 
 
 statistical analysis 
for understanding 
the effect of the 
environmental 
temperature on the 
exponential growth 
rate of the cases 
infected by 
COVID-19 for US 
and Italian regions.  
Growth rate 
 
6 
cases infected 
by COVID-19 
 
 The results clearly 
support the first 
reported statistically 
significant relationship 
of negative correlation 
between the average 
environmental 
temperature and 
exponential growth 
rates of the infected 
cases. 
30.05.2020 
 
Early 
transmission of 
SARS-CoV-2 
in South Africa: 
an 
epidemiological 
and 
phylogenetic 
report 
 
medRxiv | 
Preprint (not 
peer 
reviewed) 
 
 A molecular 
epidemiological study 
by a network of 
government and 
university laboratories 
of the first 21 SARS-
CoV-2 whole genomes 
sampled in the first 
port of entry, KwaZulu-
Natal (KZN) during the 
first month of the 
epidemic 
 The early introduction 
of SARS-CoV-2 in 
KZN included a 
localised hospital 
outbreak which may 
explain the initially 
high death rates in the 
province 
 The current high rate 
of transmission of C19 
in the Western Cape 
and Eastern Cape 
highlights the need to 
strengthen local 
genomic surveillance 
in SA 
  
 
 
 
 
 
7 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
04.06.2020 Correlation 
between N95 
extended use 
and reuse and 
fit failure in an 
emergency 
department 
 
JAMA | 
Research 
Letter 
 
 There is a lack of 
empirical evidence 
on the 
effectiveness of 
N95 reuse and 
extended use 
during critical PPE 
shortages. This 
study examined the 
prevalence of N95 
fit test failure while 
reusing 2 common 
types of N95 masks 
 Duckbill N95s had 
a high failure rate. 
Failure of dome-
shaped masks was 
associated with 
increased use.  
 N95 failure may 
contribute to SARS-
CoV-2 transmission 
and based on this 
preliminary data, 
health systems 
should closely 
evaluate N95 fit 
during extended 
use or reuse and 
limit duckbill mask 
use if alternatives 
are available 
 Limitations, 
including the 
study’s cross-
sectional design, 
are noted 
  
Face masks 
 
   
 
 
04.06.2020 
 
Social network-
based 
distancing 
strategies to 
flatten the 
COVID-19 curve 
Nature 
Human 
Behaviour | 
Article 
 
 Social, psychological 
and economic 
consequences of 
complete or near-
complete lockdown 
demand more 
moderate contact-
reduction policies 
Social 
distancing, 
behaviour, 
infection control 
 
8 
in a post-
lockdown world 
 
 The effectiveness of 
3 distancing 
strategies designed 
to keep the curve flat 
and aid compliance 
post-lockdown are 
evaluated in this 
study 
 Strategic social 
network-based 
reduction of contact 
strongly enhances 
the effectiveness of 
social distancing 
measures while 
keeping risks lower 
 
03.06.2020 
 
Seroprevalence 
of SARS-CoV-2 
in Hong Kong 
and in residents 
evacuated from 
Hubei province 
China: a 
multicohort 
study 
 
The Lancet 
Microbe | 
Article 
 
 Control measures 
implemented in 
Hong Kong and 
Hubei province 
successfully 
restricted the 
spread of SARS-
CoV-2 as of May 
2020 
 Relatively low 
seroprevalence 
suggests lack of 
herd immunity and 
susceptibility to a 
resurgence of the 
SARS-CoV-2 
epidemic if public 
health measures 
are relaxed 
 Although a small 
study size, provides 
a baseline for public 
health authorities 
when evaluating the 
effect of current and 
future interventions 
 
Seroprevalence, 
transmission, 
herd immunity 
 
 01.06.2020 
 
Physical 
distancing, face 
masks, and eye 
protection to 
prevent person-
to-person 
transmission of 
SARS-CoV-2 
The Lancet 
 
 Systematic review 
and meta-analysis to 
investigate the 
optimum distance 
for avoiding person-
to-person virus 
transmission and to 
assess the use of 
face masks and eye 
protection to prevent 
Face masks, eye 
protection 
 
9 
and COVID-19: 
a systematic 
review and 
meta-analysis 
 
transmission of 
viruses. 
 The findings of this 
systematic review 
and meta-analysis 
support physical 
distancing of 1 m or 
more and provide 
quantitative 
estimates for models 
and contact tracing 
to inform policy.  
 Optimum use of face 
masks, respirators, 
and eye protection 
in public and health-
care settings should 
be informed by 
these findings and 
contextual factors.  
 Robust randomised 
trials are needed to 
better inform the 
evidence for these 
interventions, but 
this systematic 
appraisal of 
currently best 
available evidence 
might inform interim 
guidance. 
 
 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
 04.06.2020 
 
Serodiagnostics 
for Severe Acute 
Respiratory 
Syndrome-
Related 
Coronavirus-2: A 
narrative review 
 
Annals of 
Internal 
Medicine | 
Review 
 
 Discusses key use 
cases for SARS-
CoV-2 antibody 
detection tests and 
their application to 
serologic studies 
 Reviews currently 
available assays 
 Highlights ongoing 
research 
 Proposes potential 
strategies for test 
implementation 
 Serodiagnostics 
10 
 
Therapeutics 
Publication 
date 
Title/URL Journal/A
rticle 
type 
Summary             Keywords 
03.06.2020 A randomised 
trial of 
hydroxychloroq
uine as 
postexposure 
prophylaxis for 
Covid-19 
NEJM | 
Article 
 A randomised, double-
blind, placebo-controlled 
trial across the US and 
parts of Canada testing 
hydroxychloroquine as 
postexposure 
prophylaxis 
 Hydroxychloroquine did 
not prevent illness 
compatible with C19 or 
confirmed infection when 
used within 4 days after 
high-risk or moderate-
risk exposure to C19  
 RCT, 
hydroxychloroquine
, prophylaxis 
03.06.2020 Effect of 
convalescent 
plasma therapy 
on time to 
clinical 
improvement in 
patients with 
severe and life-
threatening 
COVID-19: a 
randomised 
clinical trial 
JAMA | 
Article 
 In this randomised 
clinical trial of 103 
patients in China that 
was terminated early 
(underpowering the 
study), among patients 
with severe or life-
threatening C19, 
convalescent plasma 
therapy added to 
standard treatment did 
not significantly improve 
the time to clinical 
improvement within 28 
days 
RCT, convalescent 
plasma 
02.06.2020 G6PD variant 
distribution in 
sub-Saharan 
Africa and 
potential risks 
of using 
chloroquine/hyd
roxychloroquine 
based 
treatments for 
COVID-19 
medRxiv 
| Preprint 
(not peer 
reviewed
) 
 Chloroquine/hydroxychlo
roquine have been 
proposed as potential 
treatments for COVID-
19. These drugs have 
warning labels for use in 
individuals with glucose-
6-phosphate 
dehydrogenase (G6PD) 
deficiency. Analysis of 
whole-genome sequence 
data of 458 individuals 
from sub-Saharan Africa 
showed significant G6PD 
Drug, 
Chloroquine/hy
droxychloroqui
ne 
11 
variation across the 
continent. 
 The high prevalence of 
variants in the G6PD 
gene found in this 
analysis suggests that it 
may be a significant 
interaction factor in 
clinical trials of 
chloroquine and 
hydrochloroquine for 
treatment of COVID-19 in 
Africans. 
Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
 29.05.2020 Rapid 
assessment 
of service 
delivery for 
NCDs 
during the 
COVID-19 
pandemic 
 WHO NCD 
Department | 
Preliminary 
results 
 A survey run by WHO with 
responses from 155 
countries has shown that 
C19 significantly impacts 
health services for cancer, 
cardiovascular disease and 
diabetes 
 Countries must find 
innovative ways to continue 
essential health services 
Health 
service | 
NCD 
Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
02.06.2020 Public 
Knowledge 
and Practices 
regarding 
COVID-19: A 
cross-sectional 
survey from 
Pakistan 
medRxiv | 
Preprint (not 
peer 
reviewed) 
 Pakistani residents had 
good knowledge and 
practices towards COVID-
19 yet there are gaps in 
specific aspects of 
knowledge, and practice 
that should be focused in 
future awareness and 
educational campaigns.  
 Study recommends the 
ministry of health 
authorities promote all 
precautionary and 
preventive measures of 
COVID-19 - to all strata of 
equity 
12 
society including less 
privileged people, older 
ones and less educated 
people. 
29.05.2020 Initial 
psychological 
impact of 
COVID-19 and 
its correlates in 
Indian 
Community: 
An online 
(FEEL-COVID) 
survey 
PLOS one/ 
research 
article 
 From 26th to 29th March 
an online survey 
 1106 responses from 
around 64 cities in the 
country 
 During the initial stages of 
COVID-19 in India, almost 
one-third respondents had 
a significant psychological 
impact. This indicates a 
need for more systematic 
and longitudinal 
assessment of 
psychological needs of the 
population, which can help 
the government in 
formulating holistic 
interventions for affected 
individuals. 
   
Mental 
health 
29.05.2020 Behavioural 
health and 
response for 
COVID-19 
Disaster 
Medicine and 
Public Health 
Preparedness 
 Research suggests that 
behavioural health 
concerns should take a 
primary role in response to 
the pandemic 
 A four-step services 
system is proposed 
designed for 
implementation with a 
variety of different groups 
and reserves limited 
clinical services for the 
most extreme reactions 
Behaviour 
22.05.2020 COVID-19 
pandemic, 
socioeconomic 
crises and 
human stress 
in resource-
limited 
settings: A 
case from 
Bangladesh 
Cell | 
Research 
Article 
 Study to understand the 
public perception of 
socioeconomic crises 
and human stress in 
resource-limited 
settings of Bangladesh 
during the C19 
outbreak 
 1066 Bangladeshi 
participants  
 Mental 
health 
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Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
05.06.2020 Oxford University’s COVID-19 
vaccine: next steps towards 
broad and equitable global 
access 
University of Oxford 
| News 
  
04.06.2020 Brazilian Health Regulatory 
Agency approves trial of 
Oxford COVID-19 Vaccine 
Med Sci University 
of Oxford | News 
  
05.06.2020 Retraction – 
Hydroxychloroquine or 
chloroquine with or without a 
macrolide for treatment of 
COVID-19: a multinational 
registry analysis 
The Lancet | 
Comment 
Mandeep R Mehra 
Frank Ruschitzka 
Amit N Patel 
04.06.2020 Retraction: Cardiovascular 
disease: drug therapy, and 
mortality in Covid-19. NEJM 
DOI 10.1056/NEJMoa2007621 
NEJM | 
Correspondence 
Mandeep R Mehra 
Sapan S Desai 
SreyRam Kuy 
Timothy D Henry 
Amit N Patel 
04.06.2020 Making decisions in a COVID-
19 world 
JAMA | Viewpoint Baruch Fischoff 
04.06.2020 Is Nigeria Ready to leave 
lockdown? 
CGD | Blog Benjamin 
Uzochukwu 
Francis Ruiz 
Kalipso Chalkidou 
Eno’bong Idiong 
Samantha 
Hollingworth 
14 
04.06.2020 India’s COVID-19 testing 
capacity must grow by a factor 
of 10: here’s how that can 
happen 
CGD | Notes Prashant Yadav 
Abha Mehndiratta 
Kalipso Chalkidou 
Sidharth Rupani 
Krishna Reddy 
04.06.2020 The indirect health effects of 
COVID-19: lockdown 
measures and service 
provision 
CGD | Blog Lydia Regan 
Y-Ling Chi 
03.06.2020 As global health players pivot 
to COVID-19 responses we 
need coordinated, real-time, 
formative evaluations 
CGD | Blog Pippa Page 
Cassandra Nemzoff 
Kalipso Chalkidou 
Sam McPherson 
03.06.2020 Hydroxychloroquine for the 
prevention of COVID-19 – 
searching for evidence 
NEJM | Editorial Marc DuBois 
Julian Sheather 
Catherine R. 
McGowan 
Louisa Baxter 
Rachael Cummings 
03.06.2020 Africa’s COVID-19 resilience 
must not lead to complacency 
Chatham House | 
Comment 
Dr Knox Chitiyo 
Prof Martin Rupiya 
Pamela Wadi 
03.06.2020 A randomised trial of 
convalescent plasma for 
COVID-19 – potentially hopeful 
signals 
JAMA | Editorial   
03.06.2020 Population serology for SARS-
CoV-2 is essential to regional 
and global preparedness 
The Lancet Microbe 
| Comment 
Huaiyu Tian 
Ottar N Bjornstad 
15 
02.06.2020 Global outbreak research: 
harmony not hegemony 
The Lancet 
Infectious Diseases 
|Comment 
ISARIC clinical 
characterisation 
group 
02.06.2020 COVID-19 and essential 
pregnant worker policies 
The Lancet 
Infectious Diseases 
|Correspondence 
Elizabeth S 
McDonald 
02.06.2020 Of viruses, vaccines, and 
variability: qualitative meaning 
matters  
Trends in Cognitive 
Sciences 
Valerie F. Reyna 
28.05.2020 Covid-19 in humanitarian 
settings: addressing ethics to 
reduce moral distress 
BMJ | Opinion   
02.06.2020 Hydroxychloroquine or 
chloroquine with or without a 
macrolide for treatment of 
COVID-19: a multinational 
registry analysis 
Lancet | Expression 
of concern 
  
June 2020 Initiation of the Global Coalition 
for Radiotherapy during the 
COVID-19 pandemic 
Lancet Oncology | 
Comment 
Pat Price, Shandi E 
Barney 
02.06.2020 Global mental health and 
COVID-19 
Lancet Psychiatry | 
Comment 
Lola Kola 
02.06.2020 The need for privacy with 
public digital contact tracing 
during the COVID-19 
pandemic 
Lancet Digital 
Health | Comment 
Yoshua Bengio, 
Richard Janda et al 
02.06.2020 Thousands of people will help 
scientists to track the long-term 
health effects of the 
coronavirus crisis 
Nature |News   
02.06.2020 A Harm-Reduction Approach 
to Coronavirus Disease 2019 
JAMA Health Forum 
| Insights 
Eric Kutscher, 
Richard E. Greene 
16 
(COVID-19)—Safer 
Socializing 
26.05.2020 Why Africa struggles to test for 
covid-19 
The Economist | 
News 
  
25.05.2020 Complexity and fragility: 
realising the SDGs in 
The face of Covid-19 
4SD/ brief David Nabarro 
28.305.2020 Research on covid-19 is 
suffering “imperfect incentives 
at every stage” 
BMJ/ Blog Stephen Armstrong 
01.06.2020 Obstacles to COVID-19 control 
in east Africa 
Lancet Infectious 
Diseases/ 
Newsdesk 
Esther Nakkazi 
01.06.2020 Food insecurity will be the sting 
in the tail of COVID-19 
Lancet Global 
Health/ Editorial 
  
01.06.2020 COVID-19 effect on mental 
health: patients and workforce 
Lancet Psychiatry / 
Comment 
Victor Pereira-
Sanchez, Frances 
Adiukwu et al 
01.06.2020 Death threats in Brazil after a 
trial on chloroquine for COVID-
19 
Lancet Infectious 
Diseases/ 
Newsdesk 
Estella Ektorp 
30.05.2020 Fears of “highly catastrophic” 
COVID-19 spread in Yemen 
Lancet / World 
Report 
Sharmila Devi 
30.05.2020 COVID-19 strains remote 
regions of Peru 
Lancet / World 
Report 
Barbara Fraser 
30.05.2020 COVID-19 in Africa: no room 
for complacency 
Lancet/ Editorial   
01.06.2020 Covid-19 hot spots appear 
across Latin America 
BMJ/ News Owen Dyer 
17 
  Comment on “COVID-19 
Preparedness Within the 
Surgical, Obstetric, and 
Anesthetic Ecosystem in Sub 
Saharan Africa” 
Annals of Surgery/ 
Letter 
Starr, Nichole; 
Weiser, Thomas  
29.05.2020 Facing mental health fallout 
from the coronavirus pandemic 
WHO / News   
01.06.2020 Covid-19 and health: five 
expert views 
ODI | Blog Emma Samman 
Tom Hart 
Fiona Samuels 
Carmen Leon-
Himmelstine 
Vidya Diwakar 
May 2020 Towards universal health 
systems in the Covid-19 era: 
opportunities and threats 
ODI | Briefing paper Emma Samman 
29.05.2020 All eyes are on local 
humanitarian responders 
during Covid-19 – now they 
need support 
ODI | Comment John Bryant 
01.06.2020 COVID-19 significantly impacts 
health services for 
noncommunicable diseases 
WHO | News 
release 
  
29.05.2020 The South African Response to 
the Pandemic 
NEJM | 
Correspondence 
Salim S. Abdool 
Karim 
29.05.2020 The right to health must guide 
responses to COVID-19 
The Lancet | 
Comment 
Dainius Puras 
Judith Bueno de 
Mesquita 
Luisa Cabal  
Allan Maleche 
18 
Benjamin  Mason 
Meier 
29.05.2020 Lockdown poses new 
challenges for cancer care in 
India 
The Lancet 
Oncology | News 
Dinesh C. Sharma 
29.05.2020 Poor clinical outcomes for 
patients with cancer during the 
COVID-19 pandemic 
The Lancet 
Oncology | 
Comment 
Liang V Tang 
Yu Hu 
27.05.2020 Tracking the genomic 
footprints of SARS-CoV-2 
transmission 
Cell | Spotlight Tommy Tsan-Yuk 
Lam 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
05.06.2020 Statement from the 
Chief Investigators 
of the Randomised 
Evaluation of 
COVid-19 thERapY 
(RECOVERY) Trial 
on 
hydroxychloroquine 
RECOVERY 
Trial | 
Statement  
 At the request of the MHRA the 
independent DMC recommended 
chief investigators review the 
unblinded data on the 
hydroxychloroquine arm of the 
trial 
 No clinical benefit from use of 
hydroxychloroquine in 
hospitalised patients with COVID-
19 
 Participants are no longer to be 
enrolled to the 
hydroxychloroquine arm of the 
RECOVERY trial with immediate 
effect 
 Full results will be made available 
as soon as possible 
01.06.2020 Maintaining 
essential health 
services: 
operational 
guidance for the 
COVID-19 context 
WHO | 
Interim 
guidance 
 Note an update to interim 
guidance issues on 25 March 
2020 
 Practical actions that countries 
can take at national, subregional 
and local levels to reorganise and 
safely delivery high-quality 
essential health services in the 
pandemic context 
19 
 Includes sample indicators for 
monitoring essential health 
services  
 Describes considerations when to 
stop and restart services as C19 
transmission recedes and surges 
May 2020 COVID-19 
Considerations for 
home and 
community-based 
care 
SSHAP | 
Brief 
 Guidelines from LMICs recognise 
the need for supported home and 
community-based care for C19 to 
protect formal healthcare setting 
capacity and to reduce the risk of 
spread in health facilities. 
Moreover, not all will be able to 
access services or may prefer 
home care. 
 The Brief reviews existing 
guidance n home and community-
based care for C19 in different 
contexts, identifies key issues and 
offers recommendations for 
addressing gaps in home and 
community-based care 
01.06.2020 Basic Psychosocial 
Skills: A Guide for 
COVID-19 
Responders 
WHO 
 This Guide aims to help orient 
people supporting the COVID-19 
response to integrate 
psychosocial support skills into 
their daily work, thereby making a 
difference to the well-being of 
people they come into contact 
with during the pandemic.  
 The guide advises how to help 
others find their own solutions to 
their problems. 
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Date Title/URL Online 
learning/event 
Duration Lead 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
16.06.2020 Africa beyond COVID-
19 
Virtual event 1h 30 
hours 
ODI 
15.06.2020 Poverty monitoring in 
the context of Covid-
19 
Virtual event 1h 15 ODI 
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Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
05.06.2020 
12pm ET 
CGD Conversations 
on COVID-19 and 
Development: John 
Nkengasong 
Event   CGD 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
25 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa” OR “South Asia” OR “Developing” OR “low-income” OR “low 
income” OR “lower-middle income” OR “low and middle income” OR “LMIC” OR “LIC” OR “global south”) OR 
(“poverty”) OR (“equity” OR “equities”), restricted to articles published in the previous 2 to 3 days, in English. This 
is complemented by a search of the homepage of the following high-impact global health journals: The Lancet 
journals, New England Journal of Medicine, Nature, JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ 
Global Health, the PLoS journals and a Twitter search of their Twitter pages. A search also of preprints from bioRxiv 
and medRxiv. Please note that papers that have not been peer-reviewed are highlighted in red. All primary 
research papers that relate to the primary and secondary impacts of the COVID-19 response in LMICs, and disease 
control and health system responses are included. Articles related to tackling the secondary impacts on other 
sectors are not included. Additional commentaries, opinions, and commissioned pieces are selected based on 
relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This is a weekly summary of the daily COVID-19 health evidence summary (HES) which are based on 3 hours of 
desk-based research each day. The summary is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to decision 
makers which, if relevant to them, they should go to before making decisions. The HES are not intended to replace 
medical or professional advice and the researcher or the K4D consortium cannot be held responsible for any 
decisions made about COVID-19 on the basis of the HES alone. K4D services are provided by a consortium of 
leading organisations working in international development, led by the Institute of Development Studies (IDS), with 
Education Development Trust, Itad, University of Leeds Nuffield Centre for International Health and Development, 
Liverpool School of Tropical Medicine (LSTM), University of Birmingham International Development Department 
(IDD) and the University of Manchester Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for International 
Development (DFID) and its partners in support of pro-poor programmes. It is licensed for 
non-commercial purposes only. K4D cannot be held responsible for errors, omissions or any 
consequences arising from the use of information contained in this health evidence summary. 
Any views and opinions expressed do not necessarily reflect those of DFID, K4D or any other 
contributing organisation.   
© DFID - Crown copyright 2020. 
